Offers cost-free medicine to clients without having coverage protection or who will't pay for his or her Genentech drugs. [three] Main endocrine resistance was described as relapse whilst on the initial two yrs of adjuvant endocrine therapy (ET) and secondary endocrine resistance was described as relapse while on adjuvant ET https://scottc332ozj5.ourabilitywiki.com/user